Kiora Pharmaceuticals Inc (KPRX)

Finanzdaten der Kiora Pharmaceuticals Inc-Aktie (KPRX)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
	11.81%2.21	2.51	7.31	0.79	2.40
Research and Development	2.19%2.08	2.12	2.93	2.73	2.59
Operating Income/Loss	11.81%-2.21	-2.51	-7.31	-0.79	-2.40
Nonoperating Income/Loss	46.14%0.13	0.09	0.14	0.18	0.13
Income/Loss From Continuing Operations Before Tax	14.02%-2.08	-2.42	-7.17	-0.62	-2.26
Income Tax Expense/Benefit	-	-	-0.65	-0.64	-0.11
	14.02%-2.08	-2.42	-6.52	0.03	-2.15
Attributable To Parent	14.02%-2.08	-2.42	-6.52	0.03	-2.15
Basic Average Shares	47.98%6.18	4.17	-	4.29	3.99
Diluted Average Shares	47.98%6.18	4.17	-	4.36	3.99
Basic Earnings Per Share	41.38%-0.34	-0.58	-	0.01	-0.54
Diluted Earnings Per Share	41.38%-0.34	-0.58	-	0.01	-0.54